Quarterly Result30 Apr 2026, 12:44 pm
Acutaas Q4 FY26 Revenue up 40.3% to ₹4,328mn; PAT up 114.1%
AI Summary
Acutaas Chemicals Limited reported strong financial results for Q4 and the full year ended March 31, 2026. For Q4 FY26, revenue from operations grew 40.3% year-on-year to ₹4,328 million, and Profit After Tax (PAT) increased 114.1% year-on-year to ₹1,343 million, achieving its highest ever PAT margin of 31.0%. For the full year FY26, revenue from operations rose 33.0% to ₹13,394 million, with PAT surging 122.2% to ₹3,564 million. Executive Chairman & MD, Mr. Naresh Patel, highlighted the company's strategy to diversify into Battery Chemicals, Semiconductors, and Pharmaceutical CDMO, expressing confidence in delivering 25% revenue growth in FY27.
Key Highlights
- Q4 FY26 revenue from operations grew 40.3% YoY to ₹4,328 million.
- Q4 FY26 PAT increased 114.1% YoY to ₹1,343 million.
- Q4 FY26 PAT margin reached a record 31.0%.
- Full-year FY26 revenue rose 33.0% to ₹13,394 million.
- Company targets 25% revenue growth in FY27 with diversification strategy.